Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395044 · ClinicalTrials.gov registry record · Phase 2
Gabapentin Treatment of Cannabis Dependence
A Phase 2 study, sponsored by The Scripps Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00395044 is a Phase 2 study that has completed, run by The Scripps Research Institute. The registered enrollment target is 50 participants.
The verdict
NCT00395044, a Phase 2 study, has completed, sponsored by The Scripps Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a study to evaluate the efficacy of the medication gabapentin in treating persons with cannabis dependence.
Interventions
- DRUG Placebo
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-08 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00395044
The ClinicalTrials.gov registry entry for NCT00395044 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Scripps Research Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00395044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00395044 about?
NCT00395044 is a clinical study titled "Gabapentin Treatment of Cannabis Dependence". This is a study to evaluate the efficacy of the medication gabapentin in treating persons with cannabis dependence.
What is the current status of trial NCT00395044?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2006-08. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00395044?
The interventions under investigation include: Placebo (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT00395044?
This trial is sponsored by The Scripps Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.